Comparison Between Peak Systolic Velocity of the Inferior Thyroid Artery and Technetium-99m Pertechnetate Thyroid Uptake in Differentiating Graves' Disease from Thyroiditis
Overview
Authors
Affiliations
Objectives: The differentiation between the various etiologies of thyrotoxicosis, including those with hyperthyroidism (especially Graves' disease [GD], the most common cause of hyperthyroidism) and without hyperthyroidism (like thyroiditis), is an important step in planning specific therapy. Technetium-99m (99mTc) pertechnetate thyroid scanning is the gold standard in differentiating GD from thyroiditis. However, this technique has limited availability, is contraindicated in pregnancy and lactation, and is not helpful in cases with history of recent exposure to excess iodine. The aim of this study was to identify the diagnostic value of the peak systolic velocity of the inferior thyroid artery (PSV-ITA) assessed by color-flow Doppler ultrasound (CFDU) and compare the sensitivity and specificity of this method versus 99mTc pertechnetate thyroid uptake.
Subjects And Methods: We prospectively analyzed 65 patients (46 with GD and 19 with thyroiditis). All patients were evaluated with clinical history and physical examination and underwent 99mTc pertechnetate scanning and measurement of TRAb levels and PSV-ITA values by CFDU. The diagnosis was based on findings from signs and symptoms, physical examination, and 99mTc pertechnetate uptake.
Results: Patients with GD had significantly higher mean PSV-ITA values than those with thyroiditis. At a mean PSV-ITA cutoff value of 30 cm/sec, PSV-ITA discriminated GD from thyroiditis with a sensitivity of 91% and specificity of 89%.
Conclusion: Measurement of PSV-ITA by CFDU is a good diagnostic approach to discriminate between GD and thyroiditis, with sensitivity and specificity values comparable to those of 99mTc pertechnetate thyroid uptake.
Oh D, Ryoo H, Chung H, Cho S, Kwon K, Kim J BMJ Open. 2024; 14(10):e089552.
PMID: 39401965 PMC: 11475049. DOI: 10.1136/bmjopen-2024-089552.
Li S, Ding Z, Li X, Fu M, Sang L, Yang M Front Endocrinol (Lausanne). 2024; 15:1393126.
PMID: 38911037 PMC: 11190173. DOI: 10.3389/fendo.2024.1393126.
Quantitative Diagnosis Progress of Ultrasound Imaging Technology in Thyroid Diffuse Diseases.
Huang J, Zhao J Diagnostics (Basel). 2023; 13(4).
PMID: 36832188 PMC: 9954877. DOI: 10.3390/diagnostics13040700.
Assem Hussein M, Abdel Hamid A, M Abdel Samie R, Hussein E, Sadik Elsawy S Int J Gen Med. 2022; 15:7131-7144.
PMID: 36110917 PMC: 9470082. DOI: 10.2147/IJGM.S375016.
Hyperthyroidism in children and adolescents: Experience in a university hospital in Colombia.
Garcia J, Sarmiento M, Bello J, Zuluaga N, Forero A, Nino L Biomedica. 2022; 42(2):342-354.
PMID: 35867926 PMC: 9443673. DOI: 10.7705/biomedica.6244.